{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:32:43Z","timestamp":1790271163190,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13256-018-1801-1","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T16:26:08Z","timestamp":1535559968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ivermectin-induced fixed drug eruption in an elderly Cameroonian: a case report"],"prefix":"10.1186","volume":"12","author":[{"given":"Calypse Asangbe","family":"Ngwasiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Hongieh","family":"Abanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopold Ndemnge","family":"Aminde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,11]]},"reference":[{"issue":"2","key":"1801_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/0976-500X.184778","volume":"7","author":"J Ratinder","year":"2016","unstructured":"Ratinder J, Dinesh P, Deepa C. Fixed drug eruption due to levocetirizine. J Pharmacol Pharmacother. 2016;7(2):109\u201311.","journal-title":"J Pharmacol Pharmacother"},{"issue":"11","key":"1801_CR2","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1177\/0960327111400105","volume":"30","author":"H Akyazi","year":"2011","unstructured":"Akyazi H, Mungan S, Kara IH. Naproxen-induced fixed drug eruption: a case report. Hum Exp Toxicol. 2011;30(11):1872\u20134.","journal-title":"Hum Exp Toxicol"},{"key":"1801_CR3","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/j.1468-3083.2009.03124.x","volume":"23","author":"S Gupta","year":"2009","unstructured":"Gupta S, Gupta S, Mittal A, David S. Oral fixed drug eruption caused by gabapentin. J Eur Acad Dermatol Venereol. 2009;23:1207\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1801_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/0975-962X.154376","volume":"6","author":"R Srivastava","year":"2015","unstructured":"Srivastava R, Bihari M, Bhuvan J, Saad A. Fixed drug eruptions in intraoral presentation. Indian J Dent. 2015;6(2):103\u20136.","journal-title":"Indian J Dent"},{"issue":"5","key":"1801_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2165\/00002018-200730050-00003","volume":"30","author":"A Krahenbuhl-Melcher","year":"2007","unstructured":"Krahenbuhl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krahenbuhl S. Drug-related problems in hospitals: a review of recent literature. Drug Saf. 2007;30(5):379\u2013407.","journal-title":"Drug Saf"},{"key":"1801_CR6","first-page":"559","volume":"82","author":"R Spear","year":"2004","unstructured":"Spear R, Durrheim D. Mass treatment with ivermectin: an underutilized public health strategy. Bull World Health Organ. 2004;82:559\u2013636.","journal-title":"Bull World Health Organ"},{"issue":"49","key":"1801_CR7","first-page":"545","volume":"374","author":"WHO","year":"2014","unstructured":"WHO. Prevention, control and elimination of onchocerciasis control: progress report, 2013\u20132014. Wkly Epidemiol Rec. 2014;374(49):545\u201360.","journal-title":"Wkly Epidemiol Rec"},{"key":"1801_CR8","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1128\/AAC.15.3.372","volume":"15","author":"JR Egerton","year":"1979","unstructured":"Egerton JR, et al. Avermectins, new family of potent anthelmintic agents: efficacy of the B1 component. Antimicrob Agents Chemother. 1979;15:372\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"1801_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0007-1935(17)32393-X","volume":"136","author":"JR Egerton","year":"1980","unstructured":"Egerton JR, et al. 22, 23-Dihydroavermectin B1a, a new broad-spectrum antiparasitic agent. Br Vet J. 1980;136:88\u201397.","journal-title":"Br Vet J"},{"key":"1801_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.6308762","volume":"221","author":"WC Campbell","year":"1983","unstructured":"Campbell WC, et al. Ivermectin: a potent anti-parasitic agent. Science. 1983;221:823\u20138.","journal-title":"Science"},{"key":"1801_CR11","unstructured":"World Health Organisation. Onchocerciasis - river blindness. Geneva: World Health Organisation; 2016. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs095\/en\/ . Accessed 3 Mar 2016."},{"issue":"8","key":"1801_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.trstmh.2006.02.003","volume":"100","author":"O Veit","year":"2006","unstructured":"Veit O, Beck B, Steuerwald M, Hatz C. First case of ivermectin-induced severe hepatitis. Trans R Soc Trop Med Hyg. 2006;100(8):795\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1801_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13104-017-2500-5","volume":"10","author":"D Aroke","year":"2017","unstructured":"Aroke D, et al. Ivermectin induced Steven\u2013Johnsons syndrome: a case report. BMC Res Notes. 2017;10:179.","journal-title":"BMC Res Notes"},{"key":"1801_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"1801_CR15","first-page":"42","volume-title":"The lichenoid reaction pattern (interface dermatitis). Skin pathology","author":"D Weedon","year":"2002","unstructured":"Weedon D. The lichenoid reaction pattern (interface dermatitis). Skin pathology. 2nd ed. London: Churchill Livingstone; 2002. p. 42\u20133.","edition":"2"},{"issue":"6","key":"1801_CR16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/00015550510042859","volume":"85","author":"K Lammintausta","year":"2005","unstructured":"Lammintausta K, Kortekangas-Savolainen O. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period. Acta Derm Venereol. 2005;85(6):491\u20136.","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"1801_CR17","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1365-2133.2005.06429.x","volume":"152","author":"K Lammintausta","year":"2005","unstructured":"Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol. 2005;152(5):968\u201374.","journal-title":"Br J Dermatol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1801-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1801-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1801-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T17:21:08Z","timestamp":1751822468000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1801-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1801"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1801-1","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,11]]},"assertion":[{"value":"7 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from the patient who also approved use of the accompanying images.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"254"}}